ZNF442
gene geneOn this page
Also known as FLJ14356
Summary
ZNF442 (zinc finger protein 442, HGNC:20877) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 442 (Q9H7R0). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 79973 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 92 total
- MANE Select transcript:
NM_030824
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20877 |
| Approved symbol | ZNF442 |
| Name | zinc finger protein 442 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14356 |
| Ensembl gene | ENSG00000198342 |
| Ensembl biotype | protein_coding |
| Entrez | 79973 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 retained_intron
ENST00000242804, ENST00000424168, ENST00000438182, ENST00000462995, ENST00000545749
RefSeq mRNA: 2 — MANE Select: NM_030824
NM_001363774, NM_030824
CCDS: CCDS12271, CCDS86707
Canonical transcript exons
ENST00000242804 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000950971 | 12363554 | 12363671 |
| ENSE00001401270 | 12345944 | 12351318 |
| ENSE00001514852 | 12364802 | 12365243 |
| ENSE00001825985 | 12365533 | 12365683 |
| ENSE00003653340 | 12352988 | 12353114 |
| ENSE00003665193 | 12352010 | 12352070 |
Expression profiles
Bgee: expression breadth ubiquitous, 170 present calls, max score 84.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.5241 / max 85.6525, expressed in 960 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179304 | 1.4237 | 638 |
| 179305 | 1.1004 | 626 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.50 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.41 | gold quality |
| hair follicle | UBERON:0002073 | 78.89 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.34 | gold quality |
| ventricular zone | UBERON:0003053 | 75.43 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 72.01 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.39 | gold quality |
| left ovary | UBERON:0002119 | 70.29 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 69.62 | gold quality |
| cortical plate | UBERON:0005343 | 69.46 | gold quality |
| ovary | UBERON:0000992 | 69.10 | gold quality |
| right ovary | UBERON:0002118 | 69.00 | gold quality |
| popliteal artery | UBERON:0002250 | 68.86 | gold quality |
| tibial artery | UBERON:0007610 | 68.81 | gold quality |
| islet of Langerhans | UBERON:0000006 | 68.78 | gold quality |
| diaphragm | UBERON:0001103 | 68.27 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 67.36 | silver quality |
| right lobe of liver | UBERON:0001114 | 67.08 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 67.05 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 67.05 | gold quality |
| aorta | UBERON:0000947 | 66.94 | gold quality |
| colonic epithelium | UBERON:0000397 | 66.73 | silver quality |
| tibial nerve | UBERON:0001323 | 65.92 | gold quality |
| embryo | UBERON:0000922 | 65.63 | gold quality |
| buccal mucosa cell | CL:0002336 | 65.52 | gold quality |
| sural nerve | UBERON:0015488 | 65.27 | silver quality |
| ectocervix | UBERON:0012249 | 65.19 | gold quality |
| metanephros | UBERON:0000081 | 64.95 | gold quality |
| stromal cell of endometrium | CL:0002255 | 64.94 | gold quality |
| left coronary artery | UBERON:0001626 | 64.85 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10137 | no | 265.51 |
| E-ANND-3 | no | 4.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting ZNF442, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-3940-5P | 99.14 | 65.26 | 493 |
| HSA-MIR-4507 | 99.14 | 65.27 | 515 |
| HSA-MIR-331-3P | 98.76 | 64.91 | 793 |
| HSA-MIR-4752 | 98.71 | 68.04 | 833 |
| HSA-MIR-3691-5P | 98.62 | 65.88 | 552 |
| HSA-MIR-3188 | 98.58 | 65.60 | 878 |
| HSA-MIR-7114-5P | 98.51 | 67.87 | 1349 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-376B-5P | 98.46 | 66.40 | 606 |
| HSA-MIR-376C-5P | 98.46 | 66.64 | 589 |
| HSA-MIR-6801-3P | 98.04 | 64.64 | 805 |
| HSA-MIR-6810-3P | 97.96 | 64.57 | 1023 |
| HSA-MIR-6824-5P | 97.41 | 68.43 | 583 |
| HSA-MIR-7855-5P | 97.39 | 67.18 | 925 |
| HSA-MIR-8056 | 97.15 | 64.49 | 769 |
| HSA-MIR-584-5P | 95.82 | 68.05 | 848 |
| HSA-MIR-4278 | 95.28 | 65.49 | 351 |
| HSA-MIR-5191 | 95.22 | 64.69 | 354 |
| HSA-MIR-6732-5P | 93.97 | 64.65 | 422 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp961 | ENSMUSG00000052446 |
| rattus_norvegicus | Zfp617 | ENSRNOG00000049856 |
Paralogs (15): ZNF14 (ENSG00000105708), ZNF57 (ENSG00000171970), ZNF791 (ENSG00000173875), ZNF443 (ENSG00000180855), ZNF101 (ENSG00000181896), ZNF563 (ENSG00000188868), ZNF799 (ENSG00000196466), ZNF700 (ENSG00000196757), ZNF441 (ENSG00000197044), ZNF433 (ENSG00000197647), ZNF44 (ENSG00000197857), ZNF823 (ENSG00000197933), ZNF844 (ENSG00000223547), ZNF709 (ENSG00000242852), ZNF878 (ENSG00000257446)
Protein
Protein identifiers
Zinc finger protein 442 — Q9H7R0 (reviewed: Q9H7R0)
All UniProt accessions (2): C9JC15, Q9H7R0
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H7R0-1 | 1 | yes |
| Q9H7R0-2 | 2 |
RefSeq proteins (2): NP_001350703, NP_110451* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13894, PF13912
UniProt features (26 total): zinc finger region 16, sequence variant 7, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H7R0-F1 | 70.33 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 33 (showing top):
chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, KAT5_TARGET_GENES, NKX2_3_TARGET_GENES, PRKDC_TARGET_GENES, ZNF184_TARGET_GENES, ZNF563_TARGET_GENES, MIR7114_5P, MIR6810_3P, MIR6801_3P, MIR8056, GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN, BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP, BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
252 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF442 | SLC25A44 | Q96H78 | 480 |
| ZNF442 | PTPRH | Q9HD43 | 431 |
| ZNF442 | RNF39 | Q9H2S5 | 419 |
| ZNF442 | PM20D1 | Q6GTS8 | 400 |
| ZNF442 | PXT1 | Q8NFP0 | 398 |
| ZNF442 | TMEM125 | Q96AQ2 | 398 |
| ZNF442 | ACTL9 | Q8TC94 | 381 |
| ZNF442 | KCTD20 | Q7Z5Y7 | 377 |
| ZNF442 | ADCK5 | Q3MIX3 | 370 |
| ZNF442 | STK38 | Q15208 | 366 |
| ZNF442 | ARK2C | Q6ZSG1 | 359 |
| ZNF442 | SLC44A5 | Q8NCS7 | 320 |
| ZNF442 | ZNF644 | Q9H582 | 308 |
| ZNF442 | ERGIC3 | Q9Y282 | 297 |
| ZNF442 | MT1B | P07438 | 277 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF442 | HNRNPU | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF442 | CBX3 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): ZNF442 (Proximity Label-MS), ZNF442 (Proximity Label-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
92 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 87 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
567 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12351316:CAT:C | acceptor_gain | 0.9900 |
| 19:12351319:C:CC | acceptor_gain | 0.9900 |
| 19:12352005:ATTAC:A | donor_loss | 0.9900 |
| 19:12352006:TTA:T | donor_loss | 0.9900 |
| 19:12352007:TA:T | donor_loss | 0.9900 |
| 19:12352008:A:C | donor_loss | 0.9900 |
| 19:12352009:C:CT | donor_loss | 0.9900 |
| 19:12352013:AGGCT:A | donor_gain | 0.9900 |
| 19:12352020:T:TA | donor_gain | 0.9900 |
| 19:12353125:CCACA:C | acceptor_gain | 0.9900 |
| 19:12353126:CACA:C | acceptor_gain | 0.9900 |
| 19:12365529:TCA:T | donor_loss | 0.9900 |
| 19:12365530:CA:C | donor_loss | 0.9900 |
| 19:12365531:A:AC | donor_gain | 0.9900 |
| 19:12365531:ACCA:A | donor_loss | 0.9900 |
| 19:12365532:C:CC | donor_gain | 0.9900 |
| 19:12351318:TC:T | acceptor_loss | 0.9800 |
| 19:12352066:CATTC:C | acceptor_gain | 0.9800 |
| 19:12352070:CCTAA:C | acceptor_loss | 0.9800 |
| 19:12352072:T:C | acceptor_loss | 0.9800 |
| 19:12352078:G:C | acceptor_gain | 0.9800 |
| 19:12352982:TTTTA:T | donor_loss | 0.9800 |
| 19:12352983:TTTAC:T | donor_loss | 0.9800 |
| 19:12352984:TTA:T | donor_loss | 0.9800 |
| 19:12352985:TA:T | donor_loss | 0.9800 |
| 19:12352986:A:AG | donor_loss | 0.9800 |
| 19:12352987:C:G | donor_loss | 0.9800 |
| 19:12353126:C:T | acceptor_gain | 0.9800 |
| 19:12353129:A:C | acceptor_gain | 0.9800 |
| 19:12353796:T:TG | acceptor_gain | 0.9800 |
AlphaMissense
4210 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:12350679:G:C | F302L | 0.987 |
| 19:12350679:G:T | F302L | 0.987 |
| 19:12350681:A:G | F302L | 0.987 |
| 19:12350847:G:C | F246L | 0.987 |
| 19:12350847:G:T | F246L | 0.987 |
| 19:12350849:A:G | F246L | 0.987 |
| 19:12353080:A:G | F38S | 0.984 |
| 19:12350010:G:C | F525L | 0.983 |
| 19:12350010:G:T | F525L | 0.983 |
| 19:12350012:A:G | F525L | 0.983 |
| 19:12350595:A:C | F330L | 0.983 |
| 19:12350595:A:T | F330L | 0.983 |
| 19:12350597:A:G | F330L | 0.983 |
| 19:12353079:G:C | F38L | 0.983 |
| 19:12353079:G:T | F38L | 0.983 |
| 19:12353081:A:G | F38L | 0.983 |
| 19:12349926:G:C | F553L | 0.981 |
| 19:12349926:G:T | F553L | 0.981 |
| 19:12349928:A:G | F553L | 0.981 |
| 19:12350511:A:C | F358L | 0.980 |
| 19:12350511:A:T | F358L | 0.980 |
| 19:12350513:A:G | F358L | 0.980 |
| 19:12350094:G:C | F497L | 0.977 |
| 19:12350094:G:T | F497L | 0.977 |
| 19:12350096:A:G | F497L | 0.977 |
| 19:12350259:G:C | F442L | 0.977 |
| 19:12350259:G:T | F442L | 0.977 |
| 19:12350261:A:G | F442L | 0.977 |
| 19:12350763:G:C | F274L | 0.977 |
| 19:12350763:G:T | F274L | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000029896 (19:12361843 C>A,T), RS1000045622 (19:12373533 C>T), RS1000443347 (19:12361244 A>C), RS1000672838 (19:12370933 A>G), RS1000682942 (19:12349032 A>AG), RS1000823632 (19:12370694 G>C), RS1000905347 (19:12347757 A>G), RS1000948853 (19:12370344 A>C), RS1001034592 (19:12360353 C>A,T), RS1001124022 (19:12365227 G>A), RS1001324134 (19:12367813 C>T), RS1001341096 (19:12373434 T>C), RS1001453776 (19:12373055 A>T), RS1001569831 (19:12350443 T>A,C,G), RS1001620025 (19:12362468 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| cinnamaldehyde | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| resorcinol | decreases expression | 1 |
| epigallocatechin gallate | increases expression, affects cotreatment | 1 |
| Grape Seed Proanthocyanidins | decreases expression, affects cotreatment | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.